Clinical Trials Browser

NIH × Prostatic Neoplasms × Lapatinib × Clear all

NCT00103194 2014-09-30

Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer

Phase 2 Completed

49 enrolled 8 charts

Prostatic Neoplasms

NCT00095667 2013-05-08

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms